MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, R.
Right arrow Articles by Hinkle, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, R.
Right arrow Articles by Hinkle, P. M.

0026-895X/97/050785-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:785-793 (1997).

Effect of Cell Type on the Subcellular Localization of the Thyrotropin-Releasing Hormone Receptor

Run Yu and Patricia M. Hinkle

Department of Pharmacology and Physiology and the Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

The localization of an epitope-tagged receptor for thyrotropin-releasing hormone (TRH) expressed in different cell contexts was studied with immunofluorescence microscopy. In pituitary lactotrophs, which normally express TRH receptors, and in AtT20 pituitary corticotrophs, TRH receptor immunoreactivity was primarily confined to the plasma membrane. In HEK 293 and COS7 cells, TRH receptors were predominantly intracellular. In transiently transfected COS7 cells, the TRH receptor colocalized with endoplasmic reticulum and Golgi markers. The pattern of TRH receptor immunofluorescence was the same over a wide range of receptor expression in transiently transfected COS7 cells, and all cell lines bound similar amounts of 3H- and rhodamine-labeled TRH analogs, suggesting that cell-specific differences in TRH receptor localization were not simply the result of overexpression. In all cell contexts, TRH receptors on the plasma membrane underwent extensive ligand-driven endocytosis. Inhibitors of glycosylation did not alter the subcellular distribution of receptors. In HEK 293 cells expressing the transfected TRH receptor, protein synthesis inhibitors caused translocation of intracellular receptors to the cell surface, as shown by a marked increase in cell surface immunofluorescence and [3H][N3-methyl-His2]TRH binding. These results demonstrate that the subcellular localization of the TRH receptor depends on the cell context in which it is expressed and that intracellular receptors are capable of translocation to the plasma membrane.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C.-C. Zhu, L. B. Cook, and P. M. Hinkle
Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation
J. Biol. Chem., July 26, 2002; 277(31): 28228 - 28237.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. S. Nelson, M. Ikeda, H. S. Gompf, M. L. Robinson, N. K. Fuchs, T. Yoshioka, K. A. Neve, and C. N. Allen
Regulation of Melatonin 1a Receptor Signaling and Trafficking by Asparagine-124
Mol. Endocrinol., August 1, 2001; 15(8): 1306 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. F. O’Dowd, D. K. Lee, W. Huang, T. Nguyen, R. Cheng, Y. Liu, B. Wang, M. C. Gershengorn, and S. R. George
TRH-R2 Exhibits Similar Binding and Acute Signaling but Distinct Regulation and Anatomic Distribution Compared with TRH-R1
Mol. Endocrinol., January 1, 2000; 14(1): 183 - 193.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Yu and P. M. Hinkle
Signal Transduction and Hormone-dependent Internalization of the Thyrotropin-releasing Hormone Receptor in Cells Lacking Gq and G11
J. Biol. Chem., May 28, 1999; 274(22): 15745 - 15750.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Drmota, G. W. Gould, and G. Milligan
Real Time Visualization of Agonist-mediated Redistribution and Internalization of a Green Fluorescent Protein-tagged Form of the Thyrotropin-releasing Hormone Receptor
J. Biol. Chem., September 11, 1998; 273(37): 24000 - 24008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Yu and P. M. Hinkle
Signal Transduction, Desensitization, and Recovery of Responses to Thyrotropin-Releasing Hormone after Inhibition of Receptor Internalization
Mol. Endocrinol., May 1, 1998; 12(5): 737 - 749.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. R. Burt, M. Sautel, M. A. Wilson, S. Rees, A. Wise, and G. Milligan
Agonist Occupation of an alpha 2A-Adrenoreceptor-Gi1alpha Fusion Protein Results in Activation of Both Receptor-linked and Endogenous Gi Proteins. COMPARISONS OF THEIR CONTRIBUTIONS TO GTPase ACTIVITY AND SIGNAL TRANSDUCTION AND ANALYSIS OF RECEPTOR-G PROTEIN ACTIVATION STOICHIOMETRY
J. Biol. Chem., April 24, 1998; 273(17): 10367 - 10375.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Hurt, F. Y. Feng, and B. Kobilka
Cell-type Specific Targeting of the alpha 2c-Adrenoceptor. EVIDENCE FOR THE ORGANIZATION OF RECEPTOR MICRODOMAINS DURING NEURONAL DIFFERENTIATION OF PC12 CELLS
J. Biol. Chem., November 3, 2000; 275(45): 35424 - 35431.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics